(MoneyNewsWire.Net, January 11, 2018 ) According to the report Leukemia Therapeutics Market, published by Market Data Forecast, the Global market is projected to reach USD 9.60 billion by 2022, at a CAGR of 9.5% from 2017 to 2022.
Leukemia is a kind of blood cancer which causes abnormal growth of White Blood Cells, also referred to as leukocytes. This abnormal growth causes the crowd in bone marrow and other organs of the body such as spleen, liver and kidneys and disrupts their normal functioning. High exposure to radiations, genetic factors and unhealthy lifestyle are some of the main reasons behind this disease.
Get a comprehensive overview of the Leukemia Therapeutics Market: https://www.marketdataforecast.com/market-reports/global-leukemia-therapeutics-market-822/
Leukemia Therapeutics Market: Drivers & Restraints
Increasing aging populace is one of the main reason behind the growth of this market because of its high prevalence in middle-aged people and senior citizens. Moreover, increasing investments in R&D sector of healthcare is leading to new innovations in this market and ultimately helping in the growth of this market.
However, high costs of treatments and medicines are the major issues hampering the growth of this market.
Get accurate market forecast and analysis on the Leukemia Therapeutics Market. Request a sample to stay up-to-date on the main trends affecting this market: https://www.marketdataforecast.com/market-reports/global-leukemia-therapeutics-market-822/request-sample
Leukemia Therapeutics Market: Segmentation
By Disease Condition
• Chronic Lymphatic Leukemia
• Acute Lymphatic Leukemia
• Chronic Myeloid Leukemia
• Acute Myeloid Leukemia
• CT Scan
• Radiation therapy
• Targeted Therapy
• Bone marrow transplant
• Stem Cell Therapy
• North America
o United States
• Asia Pacific
o South Korea
• Latin America
o Rest of Latin America
• Middle East & Africa
o Middle East
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at: https://www.marketdataforecast.com/market-reports/global-leukemia-therapeutics-market-822/customize-report
Leukemia Therapeutics Market: Overview
On the basis of disease condition, chronic myeloid leukemia dominated the market in 2017 because of its high prevalence in middle-aged people. Bone marrow transplant and stem cell therapy are growing at a very fast rate and currently, a major trend in leukemia therapeutics market. On the basis of drugs, Gleevec is the major contributor.
North America leads the global market in terms of its market share, followed in line by Europe. Main reason behind this is the rising prevalence of cervical cancer and increasing awareness of people towards it in these regions is helping the leukemia therapeutics market. Asia Pacific is growing at the fastest rate in terms of the CAGR.
Leukemia Therapeutics Market: Key Players
Major players in the Leukemia Therapeutics market are GlaxoSmithKline Pharmaceuticals Limited, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, Novartis International AG, Eisai Co. Ltd, ERYtech Pharma, Biogen Idec, Genmab A/S, Celgene Corporation, Clavis Pharma, Cephalon Inc., and Pfizer Inc.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast